Rockwell Medical names iron-delivery drug Triferic; U. of Nebraska picks up $11.2 grant for nanotech delivery;

@MichaelGFierce: Special report: The race for the artificial pancreas. Report | Follow @MichaelGFierce

> Rockwell Medical now has a name for its investigational iron-delivery drug: Triferic. The FDA accepted the proposed trade name for the previously monickered soluble ferric pyrophosphate. Release

> The University of Nebraska Medical Center has been awarded a grant of more than $11.2 million from the National Institute of General Medical Sciences for its efforts in the areas of drug delivery and nanomedicine. News

> Researchers at The Rockefeller University have developed a new technique by which RNA interference can find genes that cause tumor growth in mice. Report

> Iranian scientists have created multi-layer titania nanotube arrays that can be used in targeted drug delivery. More

> Medgenics ($MEDG) said goodbye to Andrew Pearlman, who retired from his position as CEO, and the company appointed Michael Cola as the new president and chief. Release

Suggested Articles

The new digital Abilify is a breakthrough for Proteus Digital Health and its patient-tracking products, but not so much for Abilify's maker, Otsuka.

Adamis Pharmaceuticals' EpiPen contender Symjepi, which was rejected last year before the EpiPen havoc, won approval from the FDA.

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.